Related Experiment Video
Updated: Dec 31, 2025

Identification and Characterization of Immunogenic RNA Species in HDM Allergens that Modulate Eosinophilic Lung Inflammation
Published on: May 30, 2020
IL33 contributes to diesel pollution-mediated increase in experimental asthma severity
Eric B Brandt1, Paige E Bolcas1, Brandy P Ruff1
1Division of Asthma Research, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Diesel exhaust particles (DEP) worsen asthma by increasing IL33, which drives allergic inflammation. Blocking the IL33 receptor (ST2) reduced airway hyper-responsiveness in a mouse model, suggesting IL33 as a therapeutic target for severe asthma.
Area of Science:
- Immunology
- Pulmonology
- Environmental Health
Background:
- Traffic pollution, specifically diesel exhaust particles (DEP), is linked to increased asthma risk and exacerbations.
- The role of cytokines like IL-25, IL-33, and TSLP from stressed lung cells in DEP-induced asthma severity is not well understood.
Purpose of the Study:
- To investigate the contribution of IL-33 signaling to diesel exhaust particle (DEP)-induced asthma severity.
- To explore the role of the IL-33 receptor ST2 in mediating airway hyper-responsiveness and inflammation in response to DEP and allergen co-exposure.
Main Methods:
- BALB/c mice were exposed to DEP and/or house dust mite extract (HDM).
- Airway hyper-responsiveness, pulmonary inflammation, and T-cell subsets were assessed in mice with normal or deficient ST2 expression.
- In vitro studies examined cytokine secretion from lung cells and bone marrow-derived dendritic cells (BMDCs) following HDM and/or DEP exposure.
Main Results:
- DEP exposure alone induced oxidative stress and IL-6 but not allergic features; co-exposure with HDM increased IL-33 and Th2 responses.
- ST2 deficiency partially protected against HDM + DEP-induced airway hyper-responsiveness and type 2 inflammation.
- IL-33 signaling in dendritic cells and T-cells was crucial for HDM + DEP-induced cytokine secretion (IL-5, IL-13, IL-6, IL-17A) and mixed Th2/Th17 responses.
Conclusions:
- IL-33 contributes to DEP-enhanced allergen-induced Th2 inflammation and airway hyper-responsiveness in a severe asthma mouse model.
- This effect may involve the accumulation of pathogenic IL-5+ IL-17A+ CD4+ effector T-cells.
- Targeting IL-33 signaling could be a potential therapeutic strategy for severe, steroid-resistant asthma exacerbated by traffic pollution.
More Related Videos
Related Concept Videos
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Asthma-I: Introduction
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.

